 Heron Therapeutics, Inc. NASDAQ:HRTX Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants David Szekeres Executive Vice President, Chief Operating Officer Barry Quart Chief Executive Officer and Chairman John Poyhonen President and Chief Commercial Officer Conference Call Participants Josh Schimmer Evercore Serge Belanger Needham and Company Operator Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Q2 2022 Earnings Conference. 